Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

Official record

Identifier

NCT07203482

Recruiting locations

country

United States

Interventions studied

Not provided in the official record

Lead sponsor

NYU Langone Health

Target enrolment

300 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Recruiting

First posted

Oct 2, 2025

Last updated on the registry

Jul 30, 2026

Age

40 Years – 95 Years

Sex

MALE

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Males, ages 40-95
* Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
* Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) that select focal HIFU prostate ablation as their treatment option will be offered inclusion into this prospective data collection research database.
* Patients who have early (Gleason 6 or 7), low grade cancer that is confined to the prostate.
* Willing and able to provide consent.

Exclusion Criteria:

* Patients that are not diagnosed with prostate cancer.
* Patients that are diagnosed with clinically localized prostate cancer, but select other tratment options as their desired treatment.
* Patients that are not willing or are not able to give consent.